Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pharmacyte Biotech Inc (NQ: PMCB ) 1.810 -0.060 (-3.21%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pharmacyte Biotech Inc < Previous 1 2 3 4 Next > PharmaCyte Biotech Announces Genetic Stability of Cytochrome P450 Gene and Site of Integration February 22, 2022 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate February 14, 2022 PharmaCyte Biotech Inc (NASDAQ: PMCB) updated its activities to lift the FDA's clinical hold on PharmaCyte's treatment for locally advanced, inoperable... Via Benzinga PharmaCyte Biotech Updates Status of Investigational New Drug Application to FDA February 14, 2022 From PharmaCyte Biotech, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session February 01, 2022 Gainers Epizyme (NASDAQ:EPZM) shares incr... Via Benzinga PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference January 06, 2022 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells January 04, 2022 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study December 28, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights December 15, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay December 08, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study November 30, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation November 12, 2021 From PharmaCyte Biotech, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 November 08, 2021 Upgrades For Nektar Therapeutics (NASDAQ: Via Benzinga 64 Biggest Movers From Yesterday October 28, 2021 Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 27, 2021 Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7... Via Benzinga 60 Biggest Movers From Yesterday October 27, 2021 Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the... Via Benzinga PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA September 27, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests September 21, 2021 From PharmaCyte Biotech, Inc. Via Business Wire Why Are PharmaCyte Shares Moving Higher On Thursday? September 16, 2021 PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate. These... Via Benzinga PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA September 16, 2021 From PharmaCyte Biotech, Inc. Via Business Wire 41 Stocks Moving In Friday's Mid-Day Session September 10, 2021 Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic... Via Benzinga 60 Biggest Movers From Friday September 13, 2021 Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... Via Benzinga Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday? September 09, 2021 The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today. Investors are expecting a major announcement from the company... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 09, 2021 Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff... Via Benzinga PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference September 08, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study August 31, 2021 From PharmaCyte Biotech, Inc. Via Business Wire PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise August 25, 2021 From PharmaCyte Biotech, Inc. Via Business Wire 60 Biggest Movers From Yesterday August 24, 2021 Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... Via Benzinga PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules August 23, 2021 From PharmaCyte Biotech, Inc. Via Business Wire 35 Stocks Moving In Monday's Mid-Day Session August 23, 2021 Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value... Via Benzinga 25 Stocks Moving in Monday's Pre-Market Session August 23, 2021 Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
